Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gréta Lente"'
Autor:
Andrea Tóth, Gréta Lente, Dávid Máté Csiki, Enikő Balogh, Árpád Szöőr, Béla Nagy, Viktória Jeney
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Introduction: Vascular calcification is accelerated in patients with chronic kidney disease (CKD) and increases the risk of cardiovascular events. CKD is frequently associated with anemia. Daprodustat (DPD) is a prolyl hydroxylase inhibitor for the t
Externí odkaz:
https://doaj.org/article/382afcd46db547bd8560f033e46cd144
Autor:
Dávid Máté Csiki, Haneen Ababneh, Andrea Tóth, Gréta Lente, Árpád Szöőr, Anna Tóth, Csaba Fillér, Tamás Juhász, Béla Nagy, Enikő Balogh, Viktória Jeney
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionValve calcification (VC) is a widespread complication in chronic kidney disease (CKD) patients. VC is an active process with the involvement of in situ osteogenic transition of valve interstitial cells (VICs). VC is accompanied by the act
Externí odkaz:
https://doaj.org/article/9ac33bedd00c4c57b24ab9eeefa54805
Autor:
Andrea Tóth, Dávid Máté Csiki, Béla Nagy, Enikő Balogh, Gréta Lente, Haneen Ababneh, Árpád Szöőr, Viktória Jeney
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Aims: Chronic kidney disease (CKD) is frequently associated with other chronic diseases including anemia. Daprodustat (DPD) is a prolyl hydroxylase inhibitor, a member of a family of those new generation drugs that increase erythropoiesis via activat
Externí odkaz:
https://doaj.org/article/1b36c0396d4b4845b4eb5c680dbc9143
Autor:
Dávid Máté Csiki, Haneen Ababneh, Andrea Tóth, Gréta Lente, Árpád Szöőr, Anna Tóth, Csaba Fillér, Tamás Juhász, Béla Nagy, Enikő Balogh, Viktória Jeney
AimsValve calcification (VC) is a widespread complication in chronic kidney disease (CKD) patients on hemodialysis. VC is an active process with the involvement ofin situosteogenic transition of valve interstitial cells (VICs). VC is accompanied by t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9a5320434f8e7b77be6410efa6e9d84
https://doi.org/10.1101/2023.02.08.527686
https://doi.org/10.1101/2023.02.08.527686
Autor:
Andrea, Tóth, Dávid Máté, Csiki, Béla, Nagy, Enikő, Balogh, Gréta, Lente, Haneen, Ababneh, Árpád, Szöőr, Viktória, Jeney
Publikováno v:
Frontiers in pharmacology. 13
Autor:
Zsanett Sári, Edit Mikó, Tünde Kovács, Laura Jankó, Tamás Csonka, Gréta Lente, Éva Sebő, Judit Tóth, Dezső Tóth, Péter Árkosy, Anita Boratkó, Gyula Ujlaki, Miklós Török, Ilona Kovács, Judit Szabó, Borbála Kiss, Gábor Méhes, James J. Goedert, Péter Bai
Publikováno v:
Cancers
Volume 12
Issue 9
Cancers, Vol 12, Iss 2411, p 2411 (2020)
Volume 12
Issue 9
Cancers, Vol 12, Iss 2411, p 2411 (2020)
Oncobiotic transformation of the gut microbiome may contribute to the risk of breast cancer. Recent studies have provided evidence that the microbiome secretes cytostatic metabolites that inhibit the proliferation, movement, and metastasis formation